Home
>
National Drug Code (NDC)
>
Corifact
Corifact - 63833-518-02 - (Factor XIII Concentrate (Human))
Drug Information of Corifact
| Product NDC: | 63833-518 |
| Proprietary Name: | Corifact |
| Non Proprietary Name: | Factor XIII Concentrate (Human) |
| Active Ingredient(s): | & nbsp; Factor XIII Concentrate (Human) |
| Administration Route(s): | |
| Dosage Form(s): | KIT |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Corifact
| Product NDC: | 63833-518 |
| Labeler Name: | CSL Behring GmbH |
| Product Type: | PLASMA DERIVATIVE |
| FDA Application Number: | BLA125385 |
| Marketing Category: | BLA |
| Start Marketing Date: | 20110217 |
Package Information of Corifact
| Package NDC: | 63833-518-02 |
| Package Description: | 1 KIT in 1 CARTON (63833-518-02) * 20 mL in 1 VIAL, SINGLE-USE (63833-528-01) * 20 mL in 1 VIAL, SINGLE-USE (63833-734-65) |
NDC Information of Corifact
| NDC Code | 63833-518-02 |
| Proprietary Name | Corifact |
| Package Description | 1 KIT in 1 CARTON (63833-518-02) * 20 mL in 1 VIAL, SINGLE-USE (63833-528-01) * 20 mL in 1 VIAL, SINGLE-USE (63833-734-65) |
| Product NDC | 63833-518 |
| Product Type Name | PLASMA DERIVATIVE |
| Non Proprietary Name | Factor XIII Concentrate (Human) |
| Dosage Form Name | KIT |
| Route Name | |
| Start Marketing Date | 20110217 |
| Marketing Category Name | BLA |
| Labeler Name | CSL Behring GmbH |
| Substance Name | |
| Strength Number | |
| Strength Unit | |
| Pharmaceutical Classes |
